All companies › OKTA

OKTA · Okta, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells10
Research cases0
Last filing2026-09-02

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-02 — Tighe Brett · sold 12,352 @ $161.05 2026-09-02 — Tighe Brett · sold 13,100 @ $162.32 2026-09-02 — Tighe Brett · sold 10,799 @ $162.98 2026-09-02 — Tighe Brett · sold 2,500 @ $164.04 2026-09-02 — Tighe Brett · sold 900 @ $165.20 2026-09-02 — Tighe Brett · sold 1,000 @ $166.21 2026-09-02 — Tighe Brett · sold 600 @ $167.09 2026-09-02 — Tighe Brett · sold 14,339 @ $158.51 2026-09-02 — Tighe Brett · sold 10,194 @ $159.42 2026-09-02 — Tighe Brett · sold 14,216 @ $160.28
2026-09-022026-09-02

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Tighe Brett Chief Financial Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $OKTA is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 12352.0, 'price': 161.0481, 'value': 1989266.13, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 13100.0, 'price': 162.3172, 'value': 2126355.32, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 10799.0, 'price': 162.981, 'value': 1760031.82, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 2500.0, 'price': 164.0376, 'value': 410094.0, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 900.0, 'price': 165.1956, 'value': 148676.04, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 1000.0, 'price': 166.205, 'value': 166205.0, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 600.0, 'price': 167.0867, 'value': 100252.02, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 14339.0, 'price': 158.51, 'value': 2272874.89, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 10194.0, 'price': 159.4207, 'value': 1625134.62, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Tighe Brett', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 14216.0, 'price': 160.2827, 'value': 2278578.86, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for OKTA today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.